GVAG
TELA icon

Great Valley Advisor Group’s TELA Bio TELA Stock Holding History

Great Valley Advisor Group’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Buy
19,703
+101
+0.5% +$88 ﹤0.01% 995
2025
Q4 		$23.1K Buy
+19,602
New +$24.8K ﹤0.01% 937

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Great Valley Advisor Group's TELA Position: Q1 2026 in Review

Great Valley Advisor Group increased its TELA Bio (TELA) stake by 0.52% in Q1 2026, buying an estimated $88 and bringing the position to 19,703 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Great Valley Advisor Group first reported a position in TELA in Q4 2025 and has held it in 2 quarters since. The position peaked at $23.1K in Q4 2025. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Great Valley Advisor Group held 19,703 shares of TELA Bio worth $12.2K as of Q1 2026.
  • Great Valley Advisor Group bought 101 TELA Bio shares in Q1 2026, an estimated $88.
  • TELA Bio made up ﹤0.01% of Great Valley Advisor Group's portfolio in Q1 2026, its #995 holding.
  • Great Valley Advisor Group first reported a position in TELA Bio in Q4 2025 and has held it in 2 quarters since.
  • Great Valley Advisor Group's TELA Bio position peaked at $23.1K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.